THE BEST SIDE OF ABBV-744 CLINICAL TRIAL PHASE 2 DATA

In Segment A, contributors will acquire distinctive doses and schedules of oral ABBV-744 tablet to recognize Protected dosing regimen. Supplemental members is going to be enrolled in the discovered monotherapy dosign routine. In Phase B, individuals will receive oral ruxolitinib and ABBV-744 are going to be supplied as "incorporate-on" therapy. In